HC Wainwright & Co. Reiterates Buy on Immunocore Hldgs, Maintains $90 Price Target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $90 price target.

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $90 price target.

Total
0
Shares
Related Posts